Chinese Shares Fall on Continued Concerns Over Economic Outlook
Chinese shares opened lower as investors remain concerned about growth prospects next year for the world’s second largest economy. Continue reading
- Supported exchanges /
- SHE /
- 300122.SHE
Chongqing Zhifei Bio Products (300122 SHE) stock market data APIs
¥29.69
1.47(5.2%)
as of November 22, 2024
Price chart is built with Anychart
Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, marketing, distribution, import, and export of vaccines and biological products in China. It also provides cold storage services. The company was founded in 2002 and is based in Chongqing, China.
Chongqing Zhifei Bio Products Financial Data Overview
| 28.22 | |
| 29.69 | |
| - | |
| 29.7 | |
| 28.19 | |
| 20.38-66.7325 | |
| 67 553 M | |
| 18.3247 | |
| 2 394 M | |
| 36 432 M | |
| -0.03 | |
| 0.0283 | |
| 0.959 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'300122',
Type:
'Common Stock',
Name:
'Chongqing Zhifei Bio Products',
Exchange:
'SHE',
CurrencyCode:
'CNY',
CurrencyName:
'Renminbi',
CurrencySymbol:
'¥',
CountryName:
'China',
CountryISO:
'CN',
OpenFigi:
NULL,
ISIN:
'CNE100000V20',
CIK:
NULL,
EmployerIdNumber:
'',
FiscalYearEnd:
'December',
IPODate:
'2010-09-28',
InternationalDomestic:
'International',
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Chongqing Zhifei Bio Products Fundamental Data is available in our Financial Data APIs
- Net Revenue 36 432 M
- EBITDA 4 324 M
- Earnings Per Share 1.54
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Chongqing Zhifei Bio Products Earnings via APIs
- Latest Release 2024-10-29
- EPS/Forecast 0.63
Get Chongqing Zhifei Bio Products End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Chongqing Zhifei Bio Products latest news via APIs
GSK Partners With Zhifei to Boost Shingles Vaccine Availability in China
GSK said it has an exclusive agreement with Zhifei to co-promote its shingles vaccine Shingrix in China. Continue reading
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
